Dorzolamide Hydrochloride Solution
Product Images NDC 69315-304

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 69315-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide Hydrochloride (Edaa4f35 98f2 4429 8730 Babeb871b05b 01)

Chemical structure of dorzolamide hydrochloride, showing its detailed molecular configuration including sulfur, oxygen, nitrogen, and other atoms as depicted in the diagram.*

FDA Label Image

I (Edaa4f35 98f2 4429 8730 Babeb871b05b 02)

Dorzolamide hydrochloride 20 mg/mL ophthalmic solution in a small clear plastic bottle with a white dropper cap. The bottle features a label with fine print text but no clearly legible brand design or additional markings visible. Manufactured or labeled by Leading Pharma, LLC.*

FDA Label Image

Ii (Edaa4f35 98f2 4429 8730 Babeb871b05b 03)

Photograph showing a pair of hands holding a small ophthalmic solution bottle with a child-resistant cap. The bottle is labeled, and the cap is secured with a plastic safety seal. The image highlights the proper handling or opening step with a black arrow pointing to the cap.*

FDA Label Image

Iii (Edaa4f35 98f2 4429 8730 Babeb871b05b 04)

An instructional illustration showing hands removing the protective cap from a small plastic bottle of ophthalmic solution. The bottle has a label with text and an orange dropper tip, indicating it is likely a medication intended for eye use.*

FDA Label Image

Iv (Edaa4f35 98f2 4429 8730 Babeb871b05b 05)

An instructional illustration showing hands holding an ophthalmic solution bottle, demonstrating the twisting off of the orange protective cap as indicated by a black arrow, likely for Dorzolamide hydrochloride 20 mg/mL solution by Leading Pharma, LLC.*

FDA Label Image

V (Edaa4f35 98f2 4429 8730 Babeb871b05b 06)

An instructional image labeled Figure E showing a person instilling ophthalmic solution into the eye. A hand holds a small dropper bottle above the open eye, while the other hand gently pulls down the lower eyelid to receive the drop.*

FDA Label Image

Vi (Edaa4f35 98f2 4429 8730 Babeb871b05b 07)

An instructional illustration showing a person holding an ophthalmic solution bottle labeled Dorzolamide hydrochloride. The image focuses on twisting off or removing the cap, with a black arrow indicating the direction to turn the cap. The bottle label text is present but not legible.*

FDA Label Image

Carton (Edaa4f35 98f2 4429 8730 Babeb871b05b 08)

Packaging label for Dorzolamide HCl Ophthalmic Solution USP, 2%, an eye drop solution for topical eye application. The label shows a 5 mL bottle distributed by Leading Pharma, LLC, with usage directions and storage information. The product is manufactured by FDC Limited in India and includes details on ingredients and usage instructions.*

FDA Label Image

Carton 10 mL (Edaa4f35 98f2 4429 8730 Babeb871b05b 09)

Label for Dorzolamide HCl Ophthalmic Solution USP, 2%, an eye drop solution by Leading Pharma, LLC. The 10 mL package shows storage instructions (20°-25°C), manufacturing details by FDC Limited in India, and usage steps with illustrations. It lists active and inactive ingredients, preservative, and cautions on sterility and contamination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.